世界の組換えエリスロポエチン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Recombinant Erythropoietin Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5985 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、組換えエリスロポエチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（rhEPO、赤血球生成刺激剤（ESA））、用途別市場規模（慢性腎臓病、がん関連貧血、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・組換えエリスロポエチンの市場動向 ・企業の競争状況、市場シェア ・組換えエリスロポエチンの種類別市場規模と予測2016-2027（rhEPO、赤血球生成刺激剤（ESA）） ・組換えエリスロポエチンの用途別市場規模と予測2016-2027（慢性腎臓病、がん関連貧血、その他） ・組換えエリスロポエチンの北米市場規模2016-2027（アメリカ、カナダ） ・組換えエリスロポエチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・組換えエリスロポエチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・組換えエリスロポエチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・組換えエリスロポエチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Johnson & Johnson、Kyowa Hakko Kirin、Roche、3SBio Group、Celltrion, Inc、Teva Pharmaceutical Industries Ltd、F. Hoffmann-La Roche Ltd、LG Life Sciences Ltd、Biocon Limited、Intas Pharmaceuticals Ltd、Sun Pharmaceutical Industries Ltd、Dr. Reddy's Laboratories Ltd） ・結論

Market Analysis and Insights: Global Recombinant Erythropoietin Market
The global Recombinant Erythropoietin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Erythropoietin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Erythropoietin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Erythropoietin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Erythropoietin market.

Global Recombinant Erythropoietin Scope and Market Size
Recombinant Erythropoietin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Erythropoietin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
rhEPO
Erythropoiesis-Stimulating Agents (ESA)

Segment by Application
Chronic Kidney Disease
Cancer Related Anemia
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Roche
3SBio Group
Celltrion, Inc
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
LG Life Sciences Ltd
Biocon Limited
Intas Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr. Reddy’s Laboratories Ltd

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Erythropoietin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 rhEPO
1.2.3 Erythropoiesis-Stimulating Agents (ESA)
1.3 Market by Application
1.3.1 Global Recombinant Erythropoietin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chronic Kidney Disease
1.3.3 Cancer Related Anemia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Recombinant Erythropoietin Market Perspective (2016-2027)
2.2 Recombinant Erythropoietin Growth Trends by Regions
2.2.1 Recombinant Erythropoietin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant Erythropoietin Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant Erythropoietin Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant Erythropoietin Industry Dynamic
2.3.1 Recombinant Erythropoietin Market Trends
2.3.2 Recombinant Erythropoietin Market Drivers
2.3.3 Recombinant Erythropoietin Market Challenges
2.3.4 Recombinant Erythropoietin Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Recombinant Erythropoietin Players by Revenue
3.1.1 Global Top Recombinant Erythropoietin Players by Revenue (2016-2021)
3.1.2 Global Recombinant Erythropoietin Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant Erythropoietin Revenue
3.4 Global Recombinant Erythropoietin Market Concentration Ratio
3.4.1 Global Recombinant Erythropoietin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Erythropoietin Revenue in 2020
3.5 Recombinant Erythropoietin Key Players Head office and Area Served
3.6 Key Players Recombinant Erythropoietin Product Solution and Service
3.7 Date of Enter into Recombinant Erythropoietin Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant Erythropoietin Breakdown Data by Type
4.1 Global Recombinant Erythropoietin Historic Market Size by Type (2016-2021)
4.2 Global Recombinant Erythropoietin Forecasted Market Size by Type (2022-2027)

5 Recombinant Erythropoietin Breakdown Data by Application
5.1 Global Recombinant Erythropoietin Historic Market Size by Application (2016-2021)
5.2 Global Recombinant Erythropoietin Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Recombinant Erythropoietin Market Size (2016-2027)
6.2 North America Recombinant Erythropoietin Market Size by Type
6.2.1 North America Recombinant Erythropoietin Market Size by Type (2016-2021)
6.2.2 North America Recombinant Erythropoietin Market Size by Type (2022-2027)
6.2.3 North America Recombinant Erythropoietin Market Size by Type (2016-2027)
6.3 North America Recombinant Erythropoietin Market Size by Application
6.3.1 North America Recombinant Erythropoietin Market Size by Application (2016-2021)
6.3.2 North America Recombinant Erythropoietin Market Size by Application (2022-2027)
6.3.3 North America Recombinant Erythropoietin Market Size by Application (2016-2027)
6.4 North America Recombinant Erythropoietin Market Size by Country
6.4.1 North America Recombinant Erythropoietin Market Size by Country (2016-2021)
6.4.2 North America Recombinant Erythropoietin Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Recombinant Erythropoietin Market Size (2016-2027)
7.2 Europe Recombinant Erythropoietin Market Size by Type
7.2.1 Europe Recombinant Erythropoietin Market Size by Type (2016-2021)
7.2.2 Europe Recombinant Erythropoietin Market Size by Type (2022-2027)
7.2.3 Europe Recombinant Erythropoietin Market Size by Type (2016-2027)
7.3 Europe Recombinant Erythropoietin Market Size by Application
7.3.1 Europe Recombinant Erythropoietin Market Size by Application (2016-2021)
7.3.2 Europe Recombinant Erythropoietin Market Size by Application (2022-2027)
7.3.3 Europe Recombinant Erythropoietin Market Size by Application (2016-2027)
7.4 Europe Recombinant Erythropoietin Market Size by Country
7.4.1 Europe Recombinant Erythropoietin Market Size by Country (2016-2021)
7.4.2 Europe Recombinant Erythropoietin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Recombinant Erythropoietin Market Size (2016-2027)
8.2 Asia-Pacific Recombinant Erythropoietin Market Size by Type
8.2.1 Asia-Pacific Recombinant Erythropoietin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant Erythropoietin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant Erythropoietin Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant Erythropoietin Market Size by Application
8.3.1 Asia-Pacific Recombinant Erythropoietin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant Erythropoietin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant Erythropoietin Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant Erythropoietin Market Size by Region
8.4.1 Asia-Pacific Recombinant Erythropoietin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant Erythropoietin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Recombinant Erythropoietin Market Size (2016-2027)
9.2 Latin America Recombinant Erythropoietin Market Size by Type
9.2.1 Latin America Recombinant Erythropoietin Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant Erythropoietin Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant Erythropoietin Market Size by Type (2016-2027)
9.3 Latin America Recombinant Erythropoietin Market Size by Application
9.3.1 Latin America Recombinant Erythropoietin Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant Erythropoietin Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant Erythropoietin Market Size by Application (2016-2027)
9.4 Latin America Recombinant Erythropoietin Market Size by Country
9.4.1 Latin America Recombinant Erythropoietin Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant Erythropoietin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Recombinant Erythropoietin Market Size (2016-2027)
10.2 Middle East & Africa Recombinant Erythropoietin Market Size by Type
10.2.1 Middle East & Africa Recombinant Erythropoietin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant Erythropoietin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant Erythropoietin Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant Erythropoietin Market Size by Application
10.3.1 Middle East & Africa Recombinant Erythropoietin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant Erythropoietin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant Erythropoietin Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant Erythropoietin Market Size by Country
10.4.1 Middle East & Africa Recombinant Erythropoietin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant Erythropoietin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Recombinant Erythropoietin Introduction
11.1.4 Amgen Revenue in Recombinant Erythropoietin Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Recombinant Erythropoietin Introduction
11.2.4 Johnson & Johnson Revenue in Recombinant Erythropoietin Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Kyowa Hakko Kirin
11.3.1 Kyowa Hakko Kirin Company Details
11.3.2 Kyowa Hakko Kirin Business Overview
11.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Introduction
11.3.4 Kyowa Hakko Kirin Revenue in Recombinant Erythropoietin Business (2016-2021)
11.3.5 Kyowa Hakko Kirin Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Recombinant Erythropoietin Introduction
11.4.4 Roche Revenue in Recombinant Erythropoietin Business (2016-2021)
11.4.5 Roche Recent Development
11.5 3SBio Group
11.5.1 3SBio Group Company Details
11.5.2 3SBio Group Business Overview
11.5.3 3SBio Group Recombinant Erythropoietin Introduction
11.5.4 3SBio Group Revenue in Recombinant Erythropoietin Business (2016-2021)
11.5.5 3SBio Group Recent Development
11.6 Celltrion, Inc
11.6.1 Celltrion, Inc Company Details
11.6.2 Celltrion, Inc Business Overview
11.6.3 Celltrion, Inc Recombinant Erythropoietin Introduction
11.6.4 Celltrion, Inc Revenue in Recombinant Erythropoietin Business (2016-2021)
11.6.5 Celltrion, Inc Recent Development
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Details
11.7.2 Teva Pharmaceutical Industries Ltd Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Introduction
11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2016-2021)
11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
11.8 F. Hoffmann-La Roche Ltd
11.8.1 F. Hoffmann-La Roche Ltd Company Details
11.8.2 F. Hoffmann-La Roche Ltd Business Overview
11.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Introduction
11.8.4 F. Hoffmann-La Roche Ltd Revenue in Recombinant Erythropoietin Business (2016-2021)
11.8.5 F. Hoffmann-La Roche Ltd Recent Development
11.9 LG Life Sciences Ltd
11.9.1 LG Life Sciences Ltd Company Details
11.9.2 LG Life Sciences Ltd Business Overview
11.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Introduction
11.9.4 LG Life Sciences Ltd Revenue in Recombinant Erythropoietin Business (2016-2021)
11.9.5 LG Life Sciences Ltd Recent Development
11.10 Biocon Limited
11.10.1 Biocon Limited Company Details
11.10.2 Biocon Limited Business Overview
11.10.3 Biocon Limited Recombinant Erythropoietin Introduction
11.10.4 Biocon Limited Revenue in Recombinant Erythropoietin Business (2016-2021)
11.10.5 Biocon Limited Recent Development
11.11 Intas Pharmaceuticals Ltd
11.11.1 Intas Pharmaceuticals Ltd Company Details
11.11.2 Intas Pharmaceuticals Ltd Business Overview
11.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Introduction
11.11.4 Intas Pharmaceuticals Ltd Revenue in Recombinant Erythropoietin Business (2016-2021)
11.11.5 Intas Pharmaceuticals Ltd Recent Development
11.12 Sun Pharmaceutical Industries Ltd
11.12.1 Sun Pharmaceutical Industries Ltd Company Details
11.12.2 Sun Pharmaceutical Industries Ltd Business Overview
11.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Introduction
11.12.4 Sun Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2016-2021)
11.12.5 Sun Pharmaceutical Industries Ltd Recent Development
11.13 Dr. Reddy’s Laboratories Ltd
11.13.1 Dr. Reddy’s Laboratories Ltd Company Details
11.13.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.13.3 Dr. Reddy’s Laboratories Ltd Recombinant Erythropoietin Introduction
11.13.4 Dr. Reddy’s Laboratories Ltd Revenue in Recombinant Erythropoietin Business (2016-2021)
11.13.5 Dr. Reddy’s Laboratories Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Recombinant Erythropoietin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of rhEPO
Table 3. Key Players of Erythropoiesis-Stimulating Agents (ESA)
Table 4. Global Recombinant Erythropoietin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Recombinant Erythropoietin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Recombinant Erythropoietin Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Recombinant Erythropoietin Market Share by Regions (2016-2021)
Table 8. Global Recombinant Erythropoietin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Recombinant Erythropoietin Market Share by Regions (2022-2027)
Table 10. Recombinant Erythropoietin Market Trends
Table 11. Recombinant Erythropoietin Market Drivers
Table 12. Recombinant Erythropoietin Market Challenges
Table 13. Recombinant Erythropoietin Market Restraints
Table 14. Global Recombinant Erythropoietin Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Recombinant Erythropoietin Market Share by Players (2016-2021)
Table 16. Global Top Recombinant Erythropoietin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Erythropoietin as of 2020)
Table 17. Ranking of Global Top Recombinant Erythropoietin Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Recombinant Erythropoietin Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Recombinant Erythropoietin Product Solution and Service
Table 21. Date of Enter into Recombinant Erythropoietin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Recombinant Erythropoietin Revenue Market Share by Type (2016-2021)
Table 25. Global Recombinant Erythropoietin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Recombinant Erythropoietin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Recombinant Erythropoietin Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Recombinant Erythropoietin Revenue Market Share by Application (2016-2021)
Table 29. Global Recombinant Erythropoietin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Recombinant Erythropoietin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Recombinant Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Recombinant Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Recombinant Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Recombinant Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Recombinant Erythropoietin Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Recombinant Erythropoietin Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Recombinant Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Recombinant Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Recombinant Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Recombinant Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Recombinant Erythropoietin Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Recombinant Erythropoietin Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Recombinant Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Recombinant Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Recombinant Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Recombinant Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Recombinant Erythropoietin Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Recombinant Erythropoietin Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Recombinant Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Recombinant Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Recombinant Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Recombinant Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Recombinant Erythropoietin Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Recombinant Erythropoietin Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Recombinant Erythropoietin Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Recombinant Erythropoietin Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Recombinant Erythropoietin Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Recombinant Erythropoietin Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Recombinant Erythropoietin Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Recombinant Erythropoietin Market Size by Country (2022-2027) & (US$ Million)
Table 61. Amgen Company Details
Table 62. Amgen Business Overview
Table 63. Amgen Recombinant Erythropoietin Product
Table 64. Amgen Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 65. Amgen Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Recombinant Erythropoietin Product
Table 69. Johnson & Johnson Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Kyowa Hakko Kirin Company Details
Table 72. Kyowa Hakko Kirin Business Overview
Table 73. Kyowa Hakko Kirin Recombinant Erythropoietin Product
Table 74. Kyowa Hakko Kirin Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 75. Kyowa Hakko Kirin Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Recombinant Erythropoietin Product
Table 79. Roche Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 80. Roche Recent Development
Table 81. 3SBio Group Company Details
Table 82. 3SBio Group Business Overview
Table 83. 3SBio Group Recombinant Erythropoietin Product
Table 84. 3SBio Group Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 85. 3SBio Group Recent Development
Table 86. Celltrion, Inc Company Details
Table 87. Celltrion, Inc Business Overview
Table 88. Celltrion, Inc Recombinant Erythropoietin Product
Table 89. Celltrion, Inc Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 90. Celltrion, Inc Recent Development
Table 91. Teva Pharmaceutical Industries Ltd Company Details
Table 92. Teva Pharmaceutical Industries Ltd Business Overview
Table 93. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Product
Table 94. Teva Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 95. Teva Pharmaceutical Industries Ltd Recent Development
Table 96. F. Hoffmann-La Roche Ltd Company Details
Table 97. F. Hoffmann-La Roche Ltd Business Overview
Table 98. F. Hoffmann-La Roche Ltd Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 99. F. Hoffmann-La Roche Ltd Recent Development
Table 100. LG Life Sciences Ltd Company Details
Table 101. LG Life Sciences Ltd Business Overview
Table 102. LG Life Sciences Ltd Recombinant Erythropoietin Product
Table 103. LG Life Sciences Ltd Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 104. LG Life Sciences Ltd Recent Development
Table 105. Biocon Limited Company Details
Table 106. Biocon Limited Business Overview
Table 107. Biocon Limited Recombinant Erythropoietin Product
Table 108. Biocon Limited Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 109. Biocon Limited Recent Development
Table 110. Intas Pharmaceuticals Ltd Company Details
Table 111. Intas Pharmaceuticals Ltd Business Overview
Table 112. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Product
Table 113. Intas Pharmaceuticals Ltd Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 114. Intas Pharmaceuticals Ltd Recent Development
Table 115. Sun Pharmaceutical Industries Ltd Company Details
Table 116. Sun Pharmaceutical Industries Ltd Business Overview
Table 117. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Product
Table 118. Sun Pharmaceutical Industries Ltd Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 119. Sun Pharmaceutical Industries Ltd Recent Development
Table 120. Dr. Reddy's Laboratories Ltd Company Details
Table 121. Dr. Reddy's Laboratories Ltd Business Overview
Table 122. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Product
Table 123. Dr. Reddy's Laboratories Ltd Revenue in Recombinant Erythropoietin Business (2016-2021) & (US$ Million)
Table 124. Dr. Reddy's Laboratories Ltd Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Erythropoietin Market Share by Type: 2020 VS 2027
Figure 2. rhEPO Features
Figure 3. Erythropoiesis-Stimulating Agents (ESA) Features
Figure 4. Global Recombinant Erythropoietin Market Share by Application: 2020 VS 2027
Figure 5. Chronic Kidney Disease Case Studies
Figure 6. Cancer Related Anemia Case Studies
Figure 7. Others Case Studies
Figure 8. Recombinant Erythropoietin Report Years Considered
Figure 9. Global Recombinant Erythropoietin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Recombinant Erythropoietin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Recombinant Erythropoietin Market Share by Regions: 2020 VS 2027
Figure 12. Global Recombinant Erythropoietin Market Share by Regions (2022-2027)
Figure 13. Global Recombinant Erythropoietin Market Share by Players in 2020
Figure 14. Global Top Recombinant Erythropoietin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Erythropoietin as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Recombinant Erythropoietin Revenue in 2020
Figure 16. Global Recombinant Erythropoietin Revenue Market Share by Type (2016-2021)
Figure 17. Global Recombinant Erythropoietin Revenue Market Share by Type (2022-2027)
Figure 18. North America Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Recombinant Erythropoietin Market Share by Type (2016-2027)
Figure 20. North America Recombinant Erythropoietin Market Share by Application (2016-2027)
Figure 21. North America Recombinant Erythropoietin Market Share by Country (2016-2027)
Figure 22. United States Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Recombinant Erythropoietin Market Share by Type (2016-2027)
Figure 26. Europe Recombinant Erythropoietin Market Share by Application (2016-2027)
Figure 27. Europe Recombinant Erythropoietin Market Share by Country (2016-2027)
Figure 28. Germany Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Recombinant Erythropoietin Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Recombinant Erythropoietin Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Recombinant Erythropoietin Market Share by Region (2016-2027)
Figure 38. China Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Recombinant Erythropoietin Market Share by Type (2016-2027)
Figure 46. Latin America Recombinant Erythropoietin Market Share by Application (2016-2027)
Figure 47. Latin America Recombinant Erythropoietin Market Share by Country (2016-2027)
Figure 48. Mexico Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Recombinant Erythropoietin Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Recombinant Erythropoietin Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Recombinant Erythropoietin Market Share by Country (2016-2027)
Figure 54. Turkey Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Recombinant Erythropoietin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Amgen Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 59. Kyowa Hakko Kirin Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 61. 3SBio Group Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 62. Celltrion, Inc Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 63. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 65. LG Life Sciences Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 66. Biocon Limited Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 67. Intas Pharmaceuticals Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 68. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 69. Dr. Reddy's Laboratories Ltd Revenue Growth Rate in Recombinant Erythropoietin Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---